2026 NPPES data Urology Physician NPI 1437390507 MD
Verify on CMS →

MARK KATZ, MD

Urology Physician in BOSTON, Massachusetts. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
491
Medicare Part D claims · 164 beneficiaries · Urology Physician avg: 1K
Generic prescribing
84%
generic claims · 16% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$216.22
2 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: MARK KATZ, MD is a Urology Physician ([object Object]) practicing in BOSTON, Massachusetts with a Medicare Part D prescribing footprint of 491 claims across 164 beneficiaries — 16% brand-name prescribing . Industry payments of $216.22 across 2 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: MARK KATZ, MD filed 491 Medicare Part D claims in 2023 across BOSTON, Massachusetts. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

MARK KATZ, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

MARK KATZ, MD at a glance

Quality data not reported

NPI registry status

Active

Issued 03/18/2009

NPI 1437390507

Primary specialty

Urology Physician

Mid-sized

13,350 US NPIs in this specialty

Medicare Part D claims

491 62% vs specialty avg

2023 prescription claims

Specialty avg: 1,280

Specialty distribution in Massachusetts

How Urology Physician compares to other specialties among Massachusetts providers

Massachusetts providers

Urology Physician share within Massachusetts

1. Urology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Urology Physician share within Massachusetts

Specialty board-certification context

Estimated specialty board-certified rate — Urology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Urology Physician ABMS/AOA estimate

Est. board-certified rate (Urology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Urology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MARK KATZ, MD is a Urology Physician provider practicing in BOSTON, Massachusetts, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1437390507. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

MARK KATZ, MD appears in the CMS NPPES registry as a Urology Physician provider holding MD credentials at 725 ALBANY ST, SUITE 3B, BOSTON, MA, 02118, with a listed phone of (617) 638-8485. NPI 1437390507 was issued on 03/18/2009. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what KATZ most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 491 prescription claims written by this provider, covering 164 Medicare beneficiaries and totaling roughly $54K in drug spend, split 16% brand-name and 84% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Urology Physician is a mid-sized specialty nationwide, with 13,350 enrolled providers across 54 states and an average of 1,280 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

725 ALBANY ST, SUITE 3B
BOSTON, MA 02118

Provider Details

NPI 1437390507
Specialty Urology Physician
Credentials MD
Gender Male
NPI Issued 03/18/2009

Hospital and facility affiliations

Facilities where MARK KATZ, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

BOSTON UNIVERSITY MEDICAL CENTER UROLOGISTS, INC.
BOSTON, MA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MARK KATZ, MD. Source: openpaymentsdata.cms.gov.

Total received

$216

Largest payer

PROCEPT BioRobotics Corporation

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Massachusetts BORIM 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~38K Massachusetts medical licensees in 2023 — they are NOT specific to MARK KATZ, MD. To verify MARK KATZ, MD's current license status, search the BORIM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

80
Total board actions, Massachusetts 2023
Across 78 cases
2.11
Actions per 1,000 licensees
Massachusetts statewide rate
probation
Most common action type
29 cases

BORIM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Massachusetts disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

MARK KATZ, MD — brand share 16.0%
Specialty average (est.)

16% brand-name claims vs 84% generic, on 491 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

491
Total Claims
$54K
Total Drug Cost
164
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,000
Total Day Supply
28,706
Brand vs Generic
16% brand / 84% generic
Brand Drug Cost
$45K
Generic Drug Cost
$10K
Antibiotic Claims
39

Patient Demographics

Average Patient Age
73.6 years
Avg HCC Risk Score
1.77
Gender Split
17% female / 83% male
Age Distribution
<65: 15, 65-74: 73, 75-84: 59, 85+: 17

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Tamsulosin Hcl
143
Finasteride
108
Myrbetriq
Mirabegron
60
Oxybutynin Chloride Er
Oxybutynin Chloride
38
Trospium Chloride
17
Oxybutynin Chloride
14
Doxazosin Mesylate
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Urology Physician Overview

How MARK KATZ, MD fits within the Urology Physician landscape nationally.

13,350
Urology Physician Providers in US
54
States with Urology Physician
1,280
Avg Claims per Provider

MARK KATZ, MD's 491 claims are below the specialty average of 1,280.

Nearby Urology Physician Providers in Massachusetts

Other clinicians with the same primary specialty enrolled in Massachusetts, drawn from the same CMS NPPES roster as KATZ.

Compare Urology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MARK KATZ, MD's specialty?
MARK KATZ, MD specializes in Urology Physician and practices in BOSTON, Massachusetts. Credentials: MD.
How much does MARK KATZ, MD prescribe under Medicare Part D?
In 2023, MARK KATZ, MD wrote 491 Medicare Part D claims totaling $54K in drug costs for 164 beneficiaries.
Where is MARK KATZ, MD located?
MARK KATZ, MD is located at 725 ALBANY ST, SUITE 3B, BOSTON, MA, 02118. Phone: (617) 638-8485.
What is MARK KATZ, MD's NPI number?
MARK KATZ, MD's National Provider Identifier (NPI) is 1437390507, issued on 03/18/2009.
Does MARK KATZ, MD prescribe more brand-name or generic drugs?
MARK KATZ, MD's prescribing is 16% brand-name and 84% generic drugs by claim count, with $45K in brand drug costs.
How many Urology Physician providers are there in the US?
There are 13,350 Urology Physician providers across 54 states in the US. The average Urology Physician provider writes 1,280 Medicare Part D claims per year.
What drugs does MARK KATZ, MD prescribe most often?
Based on 2023 Medicare Part D data, MARK KATZ, MD's most frequently prescribed drugs include Tamsulosin Hcl, Finasteride, Myrbetriq. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MARK KATZ, MD accept Medicare?
MARK KATZ, MD appears in CMS Medicare data with 491 Part D claims and 164 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MARK KATZ, MD's credentials?
MARK KATZ, MD's NPI is 1437390507 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology